Celgene Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (79)

Latest Posts

About This Stock More About This Stock
3 Attractive Industries For Investment
Article By: Steve Alexander
Sunday, August 19, 2018 12:04 PM EDT
Let's take a look at a few industries that - while every participant in them certainly isn't of "green dot" caliber - they still provide attractive characteristics that could produce a few select companies definitely worth a look.
In this article: ALGN, ISRG, MNST, CELG
Read
Week In Review: Shanghai Junshi Biosciences Files For $500 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, August 11, 2018 7:27 PM EDT
Shanghai Junshi Biosciences has filed for a Hong Kong IPO that is expected to raise up to $500 million. Junshi is developing a pipeline of 13 biologic drugs, including immuno-oncology treatments.
In this article: SGYP, CELG, GILD, CANF, BGNE
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich
Saturday, July 28, 2018 9:15 PM EDT
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read
Week In Review: Long Hill Capital Closes $265 Million Fund For China Healthcare
Article By: ChinaBio® Today
Saturday, July 28, 2018 4:14 PM EDT
Long Hill Capital of Beijing and Shanghai, focused the healthcare and consumer sectors, closed its second fund at $265 million. Long Hill said it "significantly exceeded” its funding target, showing the success of its thesis-investing strategy.
In this article: BMY, MRK, SNY, CELG, BGNE
Read
Biotechs Cruise Onto Green Screen: July Looks Good
Article By: Rod Raynovich
Thursday, July 19, 2018 12:16 PM EDT
Biotechs cruised through the choppy market of late June to rally with many mid-caps rolling up and major ETFs up creeping toward 2018 highs. However, with earnings reports coming up, we could expect some selling depending on top line growth.
In this article: FBT, MRK, NVS, ACAD, IBB, CELG, VRTX, XBI, NVCR, CRSP, AMGN, CTNI, JNJ
Read

PARTNER HEADLINES

Latest Tweets for $CELG

No tweets yet!

$CELG

Celgene Corporation Offers Compelling Growth Opportunity: Wedgewood
Jimmy Richards 1/31/2018 7:36:17 PM

Thanks 63 hedge funds invest in $CELG, 12 phase III programs and $100 Billion in free cash flow over the next 10 years! Stellar!

1 to 1 of 1 comments